Pembrolizumab vs. chemotherapy in the first-line setting of PD-L1 ≥ 50% metastatic non-small cell lung cancer: a real-world cost-effectiveness analysis
Liu B, Parmar A, Luo J, Dai WF, Chan KKW. Eur J Health Econ. 2025; Oct 8 [Epub ahead of print].
Liu B, Parmar A, Luo J, Dai WF, Chan KKW. Eur J Health Econ. 2025; Oct 8 [Epub ahead of print].
Antoniou T, McCormack D, Wang T, Tadrous M, Gomes T. Fundam Clin Pharmacol. 2025; 39(6):e70051.
Selick A, Campitelli MA, Huang A, Balogh R, Kurdyak P, Lunsky Y. Can J Psychiatry. 2025; Sep 29.
Fu R, Sutradhar R, Li Q, Villemure-Poliquin N, Chan KKW, Karam I, Hallet J, Eskander A. JAMA Otolaryngol Head Neck Surg. 2025; Sep 25 [Epub ahead of print].
Yuan B, Kabir M, He JC, Li Y, Grant B, Narine S, Welch M, Podolsky S, Liu N, Ajaj R, Zhan LJ, Fawzy A, Xu J, Zhang Y, Yu V, Xu W, Krishnan RG, Gallinger S, Chan KKW, Krzyzanowska MK, Truong T, Liu G, Grant RC. JCO Clin Cancer Inform. 2025; 9:e2500073. Epub 2025 Sep 25.
Kendzerska T, Saymeh M, Pugliese M, Povitz M, Robinson B, Edwards JD, To T, Gershon A. Circ Cardiovasc Qual Outcomes. 2025; e011996. Epub 2025 Sep 24.
Young JT, Tanner B, Kurdyak P. Concussion Legacy Foundation Canada. 2025 Sep 24.
Evans A, Cohen E, Stukel TA, Ante Z, Wang X, Raveedran T, Gozdyra P, Saunders N. CMAJ. 2025; 197(31):E976-E986.
Southwell A, Liddy AM, Chu A, Yu B, Fang J, Bronskill SE, Kapral M, Austin PC, Abrahamyan L, Swartz RH. Can J Neurol Sci. 2025; 1-8. Epub 2025 Sep 17.
Bjerre LM, Catley C, Smith G, Halil R, Ramsay T, Cahir C, Ryan C, Farrell B, Thavorn K, Hawken S, Gillespie U, Manuel DG, Abdulaziz KE. J Clin Epidemiol. 2025; 187:111932. Epub 2025 Aug 16.